MoonLake Immunotherapeutics

Stock Chart, Company Information, and Scan Results

$6.24(as of Sep 29, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

MoonLake Immunotherapeutics Company Information, Fundamentals, and Technical Indicators

Stock Price$6.24
Ticker SymbolMLTX
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees100
CountyUSA
Market Cap$3,936.5M

MoonLake Immunotherapeutics, a clinical stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis. The company was founded in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics In Our Stock Scanner

As of Sep 30, 2025
As of ---
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: 52-Week LowScan Type: Stock Fundamentals
As of ---
As of ---
As of ---
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.